Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

10812	Companies
234240	Keywords
163037	Articles
125255	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 03/26/2026 at 07:07, 4 months 12 days ago

Heidelberg Pharma Announces Financial Figures and Reports on Business Performance in 2025 and Outlook for 2026
Heidelberg Pharma AG reports financial figures, business performance in 2025, and outlook for 2026, including CEO appointment, cost-cutting program, and extended cash runway. Fast Track designation for HDP-101 by FDA

Financial Figures Outlook Business Performance Heidelberg Pharma Fast Track Designation
BRIEF

published on 03/18/2026 at 07:00, 4 months 20 days ago

Heidelberg Pharma recevra un paiement d'étape pour l'étude HDP-101 en Chine

Heidelberg Pharma HDP-101 Étude Clinique Paiement D'étape Médecine Huadong
BRIEF

published on 03/18/2026 at 07:00, 4 months 20 days ago

Heidelberg Pharma to Receive Milestone Payment for HDP-101 Study in China

Clinical Study Heidelberg Pharma HDP-101 Milestone Payment Huadong Medicine
PRESS RELEASE

published on 03/18/2026 at 06:55, 4 months 20 days ago

Heidelberg Pharma to Receive Milestone Payment from Partner Huadong for Clinical Study with HDP-101 in China
Heidelberg Pharma to receive milestone payment from partner Huadong for clinical study with HDP-101 in China. First patient dosed in Phase I study evaluating safety, tolerability, and efficacy

China Clinical Study Heidelberg Pharma HDP-101 Milestone Payment
BRIEF

published on 03/09/2026 at 07:17, 4 months 29 days ago

Heidelberg Pharma modifie son accord de redevances avec HealthCare Royalty et Soleus Capital se joint à la procédure.

Heidelberg Pharma Approbation De La FDA Soleus Capital Investissement En Biotechnologie Contrat De Redevances
BRIEF

published on 03/09/2026 at 07:17, 4 months 29 days ago

Heidelberg Pharma Amends Royalty Agreement with HealthCare Royalty and Soleus Capital Joins

FDA Approval Heidelberg Pharma Royalty Agreement Soleus Capital Biotech Investment
PRESS RELEASE

published on 03/09/2026 at 07:12, 4 months 29 days ago

Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital
Heidelberg Pharma AG announces amendment to royalty agreement with HealthCare Royalty and participation of Soleus Capital, securing financing until mid-2027. USD 20 million upfront from Soleus Capital and USD 25 million upon FDA approval of TLX250-Px

FDA Approval Heidelberg Pharma HealthCare Royalty Royalty Agreement Soleus Capital
BRIEF

published on 03/07/2026 at 02:08, 5 months ago

Heidelberg Pharma Modifies Royalty Agreement with HealthCare Royalty and Soleus Capital

Heidelberg Pharma HealthCare Royalty Royalty Agreement Soleus Capital TLX250-Px
BRIEF

published on 03/07/2026 at 02:08, 5 months ago

Heidelberg Pharma modifie son accord de redevances avec HealthCare Royalty et Soleus Capital

Heidelberg Pharma Soleus Capital Contrat De Redevances TLX250-Px Royauté Des Soins De Santé
PRESS RELEASE

published on 03/07/2026 at 02:03, 5 months ago

EQS-Adhoc: Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital
Heidelberg Pharma AG announces amendment to royalty agreement with HealthCare Royalty and partnership with Soleus Capital, securing upfront and milestone payments

FDA Approval HealthCare Royalty Heidelberg Pharma AG Royalty Agreement Soleus Capital

Accesswire

Published on 08/08/2026 at 00:00, 1 hour 50 minutes ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 2 hours 35 minutes ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 hours 50 minutes ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 3 hours 20 minutes ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 3 hours 35 minutes ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/07/2026 at 23:21, 2 hours 29 minutes ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 6 hours 20 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 6 hours 35 minutes ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 7 hours 40 minutes ago

Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 7 hours 50 minutes ago

E-PANGO: Composition du capital au 31 juillet 2026

Les Echos

Published on 08/07/2026 at 18:54, 6 hours 56 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 6 hours 56 minutes ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 7 hours 10 minutes ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 7 hours 10 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 7 hours 50 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE